Cumberland Pharmaceuticals (CPIX) Net Income Attributable to Noncontrolling Interests (2009 - 2026)
Cumberland Pharmaceuticals' Income from Non-Controlling Interests came in at $1,947 for Q2 2026, down 64.8% from $5,533 a year earlier and down 24.8% from the prior quarter.
Powered by 
Analysis
Cumberland Pharmaceuticals (CPIX) Net Income Attributable to Noncontrolling Interests (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Cumberland Pharmaceuticals reported Income from Non-Controlling Interests of -$20,697; for FY2025, it came in at -$28,583.
- Going back by year, Income from Non-Controlling Interests was $36,055 in FY2024, -$51,446 in FY2023, -$79,798 in FY2022 and -$95,212 in FY2021.
- The five-year range for quarterly Income from Non-Controlling Interests is -$36,561 (Q4 2021) to $43,791 (Q1 2024).
- Business Quant data shows CPIX's Income from Non-Controlling Interests at $2,588 (Q1 2026), -$16,950 (Q4 2025) and -$8,282 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCI Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 2.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -1.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 10.00 Mn |
| 10 | Cumberland Pharmaceuticals | 79.41 Mn | 79.08 Mn | - | 766.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 766.00 |
| Jun 30, 2026 | 1,947.00 |
| Mar 31, 2026 | 2,588.00 |
| Dec 31, 2025 | -16,950.00 |
| Sep 30, 2025 | -8,282.00 |
| Jun 30, 2025 | 5,533.00 |
| Mar 31, 2025 | -8,884.00 |
| Dec 31, 2024 | 2,177.00 |
| Sep 30, 2024 | 7,112.00 |
| Jun 30, 2024 | -17,025.00 |
| Mar 31, 2024 | 43,791.00 |
| Dec 31, 2023 | -7,581.00 |
| Sep 30, 2023 | -13,921.00 |
| Jun 30, 2023 | -10,046.00 |
| Mar 31, 2023 | -19,898.00 |
| Dec 31, 2022 | -18,985.00 |
| Sep 30, 2022 | -14,587.00 |
| Jun 30, 2022 | -29,046.00 |
| Mar 31, 2022 | -17,180.00 |
| Dec 31, 2021 | -36,561.00 |
API Access
Cumberland Pharmaceuticals Net Income Attributable to Noncontrolling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=CPIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "CPIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=CPIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();